Investment

Family offices behind effort to put life science, tech-driven research under one roof

Billionaires and their family offices, led by Steve Pagliuca and Michael Dell, want to boost the tech-driven revolution in life sciences by putting drug research and corporate funding under one roof.

Subscribe

You will need a Premium+ Subscription to read this article.

Exclusive news, analysis and research on global family enterprise and private investment offices

SUBSCRIBE TODAY

Already have an account? Sign in

You need a Premium subscription.

To read Premium articles please subscribe.

SUBSCRIBE TODAY

Already have an account? Sign in

You've reached the end.

Continue reading free articles by registering as a Member.
Or choose a Premium Plan.

SUBSCRIBE TODAY

Already have an account? Sign in

What to read next

Investment

In a recent survey, Family Capital found 82% of family offices made life sciences a top choice when it came to venture capital investing
Investment

Family offices frustrated by a slump in returns over the last 18 months may be relieved to learn that better ways of handling venture capital opportunities are developing at speed, fuelled by AI-driven…
Investment

Despite its recent crash, family offices and other limited partners backing VC tech are keen to invest in deals in Europe in 2024, according to an annual survey by Atomico

Leave a Reply